Department of Pathology, Faculty of Medicine, Comenius University, Sasinkova 4, 813 72 Bratislava, Slovak Republic.
Rheumatol Int. 2012 Nov;32(11):3517-23. doi: 10.1007/s00296-011-2177-3. Epub 2011 Nov 15.
The aim of this study was to evaluate the morphological changes in the spleen, the thymus and the knee joints of rats with experimental adjuvant arthritis induced by Mycobacterium butyricum in the incomplete Freund's adjuvant and the effect of treatment with methotrexate (MTX). Particular attention was aimed on the redistribution of granulocytes in the tissues during the inflammatory process. Clinical parameters, e.g., joint edema, body weight and of gamma glutamyl transferase (GGT) activity as an inflammatory marker, have also been determined. Induction of adjuvant arthritis caused a significant decrease in granulocyte number in the spleen and vice versa a significant increase in the knee joints, but without significant changes in the thymus. Treatment with methotrexate reversed this phenomenon by increasing the granulocyte number in the spleen and decreasing it in knee joints. MTX decreased the joint edema as well as the activity of GGT in the spleen, modified the size of the white pulp of the spleen and increased the cortex/medulla ratio in the thymus. The observed changes support the anti-inflammatory and immunomodulatory properties of MTX supporting its use as the first-line medication in patients with rheumatoid arthritis.
本研究旨在评估实验性佐剂性关节炎大鼠的脾脏、胸腺和膝关节的形态变化,以及甲氨蝶呤(MTX)治疗的效果。特别关注的是在炎症过程中粒细胞在组织中的重新分布。还确定了临床参数,例如关节肿胀、体重和γ-谷氨酰转移酶(GGT)活性作为炎症标志物。佐剂性关节炎的诱导导致脾脏中粒细胞数量显著减少,反之,膝关节中粒细胞数量显著增加,但胸腺中无明显变化。甲氨蝶呤治疗通过增加脾脏中粒细胞数量和减少膝关节中粒细胞数量逆转了这种现象。MTX 降低了关节肿胀和脾脏中 GGT 的活性,改变了脾脏白髓的大小,并增加了胸腺的皮质/髓质比值。观察到的变化支持了 MTX 的抗炎和免疫调节特性,支持其作为类风湿关节炎患者一线药物的使用。